Paper39680752
SREBP1c-Mediated Transcriptional Repression of YME1L1 Contributes to Acute Kidney Injury by Inducing Mitochondrial Dysfunction in Tubular Epithelial Cells.
Xin W and 14 others. Adv Sci (Weinh), 2025. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. SREBP1c-Mediated Transcriptional Repression of YME1L1 Contributes to Acute Kidney Injury by Inducing Mitochondrial Dysfunction in Tubular Epithelial Cells. Papers, record 39680752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39680752
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- SREBP1c-Mediated Transcriptional Repression of YME1L1 Contributes to Acute Kidney Injury by Inducing Mitochondrial Dysfunction in Tubular Epithelial Cells.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acute Kidney Injury | Major topic |
| Mitochondria | Major topic |
| Sterol Regulatory Element Binding Protein 1 | Major topic |
| Epithelial Cells | Major topic |
| Kidney Tubules | Major topic |
| Animals | |
| Mice | |
| Humans | |
| Cisplatin | |
| Mice, Inbred C57BL | |
| Male | |
| Disease Models, Animal |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82030023 | Key program of the Natural Science Foundation of China | PubMed | ||
| 82322012 | Natural Science Foundation of China | PubMed | ||
| U22A20279 | Natural Science Foundation of China | PubMed | ||
| 2022YFC2502500/2022YFC2502501 | National Key R&D Program of China | PubMed | ||
| cstc2021ycjh-bgzxm0145 | Chongqing Science and Technology Talent Program | PubMed | ||
| cstb2022nscq-msx0220 | Natural Science Foundation of Chongqing Science & Technology Commission | PubMed | ||
| CQYC20220511193 | Natural Science Foundation of Chongqing Science & Technology Commission | PubMed |
Source PubMed
References69
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33614729 | Pediatric Acute Kidney Injury to the Subsequent CKD Transition. | Kidney Dis (Basel) | 2021 | https://conductscience.org/library/papers/33614729 | PubMed |
| 2 | 32404507 | Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI. | Sci Transl Med | 2020 | https://conductscience.org/library/papers/32404507 | PubMed |
| 3 | 30944313 | Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. | Nat Commun | 2019 | https://conductscience.org/library/papers/30944313 | PubMed |
| 4 | 32256356 | Recent Insights Into SREBP as a Direct Mediator of Kidney Fibrosis via Lipid-Independent Pathways. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32256356 | PubMed |
| 5 | 37769864 | Regulation of renal lipid deposition in diabetic nephropathy on morroniside via inhibition of NF-KB/TNF-a/SREBP1c signaling pathway. | Chem Biol Interact | 2023 | https://conductscience.org/library/papers/37769864 | PubMed |
| 6 | 31585519 | Mitochondrial Dynamics and Its Involvement in Disease. | Annu Rev Pathol | 2020 | https://conductscience.org/library/papers/31585519 | PubMed |
| 7 | 26490400 | Transcriptional regulation of hepatic lipogenesis. | Nat Rev Mol Cell Biol | 2015 | https://conductscience.org/library/papers/26490400 | PubMed |
| 8 | 31725201 | Down-regulation of the mitochondrial i-AAA protease Yme1L induces muscle atrophy via FoxO3a and myostatin activation. | J Cell Mol Med | 2020 | https://conductscience.org/library/papers/31725201 | PubMed |
| 9 | 35986026 | Immune-mediated tubule atrophy promotes acute kidney injury to chronic kidney disease transition. | Nat Commun | 2022 | https://conductscience.org/library/papers/35986026 | PubMed |
| 10 | 30904067 | Regulated necrosis and failed repair in cisplatin-induced chronic kidney disease. | Kidney Int | 2019 | https://conductscience.org/library/papers/30904067 | PubMed |
| 11 | 32641998 | Indoxyl sulfate induces intestinal barrier injury through IRF1-DRP1 axis-mediated mitophagy impairment. | Theranostics | 2020 | https://conductscience.org/library/papers/32641998 | PubMed |
| 12 | 31575700 | Sirtuin 5 Regulates Proximal Tubule Fatty Acid Oxidation to Protect against AKI. | J Am Soc Nephrol | 2019 | https://conductscience.org/library/papers/31575700 | PubMed |
| 13 | 29242313 | Dissection of Glomerular Transcriptional Profile in Patients With Diabetic Nephropathy: SRGAP2a Protects Podocyte Structure and Function. | Diabetes | 2018 | https://conductscience.org/library/papers/29242313 | PubMed |
| 14 | 35941120 | GSDMD-dependent neutrophil extracellular traps promote macrophage-to-myofibroblast transition and renal fibrosis in obstructive nephropathy. | Cell Death Dis | 2022 | https://conductscience.org/library/papers/35941120 | PubMed |
| 15 | 30699341 | sgRNA Sequence Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing. | Cell Rep | 2019 | https://conductscience.org/library/papers/30699341 | PubMed |
| 16 | 39352860 | METTL3-Mediated N 6 -Methyladenosine mRNA Modification and cGAS-STING Pathway Activity in Kidney Fibrosis. | J Am Soc Nephrol | 2024 | https://conductscience.org/library/papers/39352860 | PubMed |
| 17 | 28890325 | AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms. | Kidney Int | 2017 | https://conductscience.org/library/papers/28890325 | PubMed |
| 18 | 35417665 | SREBP1c-PARP1 axis tunes anti-senescence activity of adipocytes and ameliorates metabolic imbalance in obesity. | Cell Metab | 2022 | https://conductscience.org/library/papers/35417665 | PubMed |
| 19 | 31695197 | Lipid signalling drives proteolytic rewiring of mitochondria by YME1L. | Nature | 2019 | https://conductscience.org/library/papers/31695197 | PubMed |
| 20 | 34049962 | Potential Therapeutic Targets for Cisplatin-Induced Kidney Injury: Lessons from Other Models of AKI and Fibrosis. | J Am Soc Nephrol | 2021 | https://conductscience.org/library/papers/34049962 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42516381 | The crucial role of N6-methyladenosine modification in acute kidney injury: mechanisms and therapeutic potential. | Front Immunol | 2026 | https://conductscience.org/library/papers/42516381 | PubMed |
| 42477459 | YME1L1 degradation by TRIM21 inhibits bladder cancer proliferation, metastasis, and mitochondrial function. | Oncogene | 2026 | https://conductscience.org/library/papers/42477459 | PubMed |
| 42238588 | Mitochondrial dysfunction in sepsis-associated acute kidney injury: mechanisms and therapeutic potential. | Front Immunol | 2026 | https://conductscience.org/library/papers/42238588 | PubMed |
| 42164653 | The Role of N6-Methyladenosine Modification in Health and Disease. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42164653 | PubMed |
| 42158947 | Response mechanism of hepatorenal metabolic barrier function to drugs and environmental poisons and intervention strategy of natural products. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42158947 | PubMed |
| 42098483 | Cycloastragenol Protects Against Cisplatin-Induced Cochlear Hair Cell Apoptosis via the PI3K/Akt/mTOR Pathway. | Cell Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42098483 | PubMed |
| 42086806 | Research progress on biomarkers for acute kidney injury in children. | Pediatr Nephrol | 2026 | https://conductscience.org/library/papers/42086806 | PubMed |
| 41940976 | Exploratory identification of lycorine as a potential inhibitor of the ACP2/YME1L1 prognostic axis in esophageal squamous cell carcinoma: a multi-omics and computational hypothesis. | Mol Genet Genomics | 2026 | https://conductscience.org/library/papers/41940976 | PubMed |
| 40893687 | Unveiling the renoprotective mechanisms of self-assembled herbal nanoparticles from Scutellaria barbata and Scleromitrion diffusum in acute kidney injury: A nano-TCM approach. | Acta Pharm Sin B | 2025 | https://conductscience.org/library/papers/40893687 | PubMed |
| 40640897 | Decoding m6A RNA methylation in kidney disorders: from molecular insights to therapeutic strategies. | J Transl Med | 2025 | https://conductscience.org/library/papers/40640897 | PubMed |
| 39680752 | SREBP1c-Mediated Transcriptional Repression of YME1L1 Contributes to Acute Kidney Injury by Inducing Mitochondrial Dysfunction in Tubular Epithelial Cells. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/39680752 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39680752
GET https://conductscience.org/api/papers/v1/39680752/references?page=2